GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genflow Biosciences GENF.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1.74p

+0.58%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Genflow Biosciences — daily GENF

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Genflow Biosciences on TradingView ↗
Market value
£8.6m
Last close × shares
Volume
2.1m
Shares, 9 Nov 2026

About Genflow Biosciences

Its shares trade on LSE under the ticker GENF.L. It has been listed since 17 January 2022. In the fiscal year to 31 December 2023, it reported revenue of £169,854 and a net loss of £1.6m. At that date it held total assets of £1.1m and shareholders' equity of £725,915.

Genflow Biosciences Plc operates as a biotechnology company, which engages in the research and development of gene therapies to counteract the effects of aging and diseases associated with advanced age. The firm is developing gene therapies designed to target the aging process and to reduce and delay the incidence of age-related diseases, which is done through therapeutics targeting aging in humans by using adeno-associated virus (AAV) vectors to deliver copies of the Sirtuin-6 (SIRT6) gene variant that is found in centenarians into cells. The firm's product line includes GF-1002, GF-3001 and GF-4001. GF-1002 is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. GF-4001 is a non-Human version of GF-1002 anti-ageing gene therapy developed for veterinary use (dogs). GF-3001 is a formulation of an adeno-associated viral vector-based gene therapy. The firm has operations in the United Kingdom and Belgium.

Figures and description from our data supplier, not checked against the company's own report.

More about Genflow Biosciences →

Latest on Genflow Biosciences

Our reporting

We have not reported on Genflow Biosciences yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Genflow Biosciences's ticker?

Genflow Biosciences trades as GENF.L on LSE, under ISIN GB00BP2C3V08.

What was Genflow Biosciences's last closing price?

1.74p on 9 Nov 2026. The figure is in GBp and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.